Novo Nordisk (NVO) has released an update.
Novo Nordisk A/S has announced an ambitious share repurchase program, with plans to buy back B shares worth up to DKK 20 billion over 12 months starting February 2024. As a part of this program, they have initiated a repurchase of shares up to DKK 2.2 billion from May to August 2024. The company’s commitment to defeating serious chronic diseases is backed by a strong heritage in diabetes care and a global presence, employing 66,000 people worldwide.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
